Biotech’s Next Era: Innovation and Commercialization

Rod Wong joins Stephanie Sirota to trace biotech's evolution. What forces built today’s innovation landscape, and what might the next decade reveal? PODCAST TEAM Producer & Director: Devon Leaver Editor: Dominique Guerra Production Coordinator: YingYu Lin Production Support: Annabelle Chan Theme music: Ganymede by Yehezkel Raz Additional music: APM Music Featuring: Rod Wong, Managing Partner and Chief Investment Officer at RTW Investments, moderated by Stephanie A. Sirota, Partner, Chief Business Officer at RTW Investments. FOLLOW US Love our podcast? Follow us on LinkedIn at RTW Investments, LP and check out our website for the latest updates and insights. To make sure you never miss an episode, you can subscribe to the RTW podcast on YouTube, Spotify, Apple Podcasts, Amazon Music, and most other podcast platforms. Learn more about 'Innovation is the Best Medicine' here. CHAPTERS 00:00 – Introduction 1:22 – Gene therapy and biotech 4:51 – Rod Wong’s journey into biotech 9:55 – Rod Wong: Investor or Business Builder? 12:43 – Growing trends in biotechnology 15:36 – Generating Alpha in Biotech 21:54 – Looking forward for RTW 23:51 - Outro DISCLAIMER This interview was given by Rod Wong, Managing Partner and Chief Investment Officer at RTW Investments, and moderated by Stephanie A. Sirota, Partner, Chief Business Officer at RTW Investments. Statements reflect RTW's views and opinions as of the date hereof and not as of any future date. All expressions of opinion are subject to change without notice and are not intended to be a forecast of future events or results. The views expressed by guests are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent.